Mission
Delta International Services &
Logistics is an agency created for the international development
of
Scrambler Therapy® Technology , a medical device for
the treatment of chronic neuropathic and oncologic pain resistant
to opiates and other types of treatment, including implanted
devices.
The scientific literature indexed and
published in peer-reviewed scientific journals, based exclusively
on this technology, shows several clinical studies on
- Symptomatic relief of chronic
opioid-resistant pain.
- Symptomatic relief of chronic
neuropathic and oncological pain.
In general, this device in the
clinical studies is indicated for forms of severe chronic pain, in
particular that which does not respond to other pharmacological
and non-pharmacological treatments, including opioids.
The Scrambler Therapy® device has been used to successfully treat
thousands of patients worldwide, where it has been shown to be
effective in treating neuropathic and oncologic pain. Scrambler
Therapy® is a stand-alone medical electro-analgesia device and
does not require combinations with other analgesic therapies.
International
distribution
DIS&L through its law
firm, is the only company authorized to sign
international exclusive agreements in all international areas
and provide maintenance and distributor support for
method usage training and other logistics needs. To request a
national exclusive agreement, the candidate distributor must
have minimum requirements listed on the “
Distributor Requirement ” page.
